Group 1 - China National Pharmaceutical Group (01177) announced that on March 27, 2026, the trustee will purchase an additional 4.65 million shares from the market [1] - The average price per share for the purchase is approximately HKD 5.8814 [1] - This transaction is conducted under the terms and conditions of the plan rules, with shares held in trust for selected participants [1]